New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Mumbai Crime: Partially Decomposed Body Of Unidentified Man Found In Sack At Juhu Beach, Murder Suspected
Baba Siddique Murder Case: ‘Prima Facie No Link To Alleged Organised Crime Conspiracy,’ Says Bombay HC While Granting Bail To Accused
Mumbai Special PMLA Court Denies Bail To Ukrainian Actor In ₹148 Crore Torres Investment Fraud Case
Mumbai Police Seize ₹58 Lakh Worth Of Banned Gutkha From Container Near Dahisar Check Post
